Complication rates after spinal cord stimulator removal vary depending on the type of lead being removed, whether other spinal surgery is performed at the same time, the amount of scar tissue surrounding the device, and the patient’s surgical history.
Published studies have reported different complication rates depending on the type and complexity of the removal procedure:
- A 2025 study of 139 patients found postoperative complications in 6.5% of patients overall. Among patients who underwent spinal cord stimulator electrode removal as a standalone procedure, the complication rate was 2.4%.
- A Cleveland Clinic study of paddle electrode removal found postoperative complications in 11.75% of patients. Major complications occurred in 2.94%, while minor complications occurred in 8.82%.
- A separate study of 131 paddle electrode explantations reported complications after 18.3% of procedures, although major complications occurred in 3.8% and no permanent neurological deficits were reported.
These findings show why there is not one complication rate that applies to every spinal cord stimulator removal.
Standalone electrode removal may carry a relatively low complication rate, while paddle lead removal can be more complex because scar tissue may form around the electrode near the spinal cord and dura.
Potential complications of removal can include infection, bleeding, hematoma, cerebrospinal fluid leaks, wound complications, retained lead fragments, worsening pain, and neurological injury.
Complications associated with the original spinal cord stimulator implantation are generally more common than complications from removal alone.
Research has reported:
- Overall device-related complication rates of approximately 30% to 40% following spinal cord stimulation treatment.
- Lead migration rates of approximately 13.2% to 22.6% in earlier studies of permanently implanted spinal cord stimulators.
- Infection rates of approximately 2% to 10% following implantation, although a large multicenter study reported an overall infection rate of 2.45%.
- Epidural hematoma rates of approximately 0.25% to 0.3% following spinal cord stimulator implantation.
- Neurological injury is considered uncommon, but reported rates vary considerably depending on the type of injury studied and how researchers collected the data.
Lead migration, infection, device failure, and other implantation complications can eventually result in revision surgery or complete removal of the spinal cord stimulator.
Patients who undergo repeated procedures or more complex paddle lead removal may face additional surgical risks because of scar tissue and changes to the tissue surrounding the spinal cord.